Biosis Plants Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.75 M
as on 15-06-2024
- Satisfied Charges ₹ 2.89 M
as on 15-06-2024
- Revenue 93.67%
(FY 2022)
- Profit 154.87%
(FY 2022)
- Ebitda 194.51%
(FY 2022)
- Net Worth 24.29%
(FY 2022)
- Total Assets 16.24%
(FY 2022)
About Biosis Plants
The Corporate was formerly known as Isis Biotechnology Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.48 Cr. The company has closed loans amounting to ₹2.89 M, as per Ministry of Corporate Affairs (MCA) records.
Tasneem Indorewala and Kauser Indorewala serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC233999
- Company No.
233999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biosis Plants?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kauser Indorewala  | Managing Director | 01-Aug-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tasneem Indorewala | Director | 15-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Biosis Plants.
Biosis Plants Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.67% increase. The company also saw a substantial improvement in profitability, with a 154.87% increase in profit. The company's net worth Soared by an impressive increase of 24.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosis Plants?
In 2022, Biosis Plants had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biochakra Plantations And Infra Private Limited
Active 3 years 5 monthsKauser Indorewala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Dec 2022 | ₹1.00 Cr | Open |
Indian Overseas Bank Creation Date: 18 Dec 2015 | ₹1.95 M | Open |
Indian Overseas Bank Creation Date: 26 Jul 2013 | ₹1.28 Cr | Open |
How Many Employees Work at Biosis Plants?
Unlock and access historical data on people associated with Biosis Plants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosis Plants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosis Plants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
